Call Me - +39 3381508675 - E-Mail: info@cyberpharmaexcellence.com

  • CONTACTS
  • SUBSCRIBE TO MAILING LIST

CYBERPHARMA EXCELLENCE

 

"The exchange of information between Pharma companies in the industry"

 

  • HOME
  • NEWS - EVENTS
    • EVENTS
    • COURSES & CONGRESSES
    • PARTNERS NEWS
    • REGULATORY NEWS
    • PHARMACOVIGILANCE
    • MINISTRY OF HEALTH
    • CYBERPHARMA EXCELLENCE NEWS
  • CM
    • DRUGS
    • COSMETICS
    • DIETARY
    • MEDICAL DEVICE
    • DATA BANKS
  • MARKET PLACE
    • OFFERS
    • REQUESTS
    • PARTNERSHIP
  • PARTNERS
    • INDEX
      • 1. PHARMACEUTICAL
        • 1.1 Raw materials
        • 1.2 Pharmaceutical Products
        • 1.3 Homeopathic Products
        • 1.4 Medical Devices
        • 1.5 Cosmetic Products
        • 1.6 Dietetic and Herbal Products
        • 1.7 Contract manufacturing production - DRUGS
        • 1.8 Contract manufacturing Production - Supplements - Cosmetics - Med. devices
        • 1.9 Machinery and Equipment
      • 2. CONTROLS, ANALYSIS AND RESEARCH
      • 3. LOGISTICS
      • 4. PACKAGING
      • 5. ORGANIZATION AND TECHNICAL CONSULTANCY
      • 6. REGULATORY AFFAIRS
      • 7. MARKETING
      • 8. HUMAN RESOURCES
      • 8.1 TECHNICAL MAGAZINES
      • 9. GENERAL SERVICES
      • 10. TRAINING COURSES
  • BECOME PARTNER
    • PARTICIPATION IN EVENTS
    • ADV-WEB
    • THE CYBERPHARMAEXCELLENCE ® PARTNER
    • NETWORK PARTNERS
      • Cybermed Europe
      • Cybermed News
      • Cybermed Junior
      • Cybermed Life
    • WORK WITH US
  • CONVENTIONS
    • BOOKS & MAGAZINES
    • HOTELS & CONFERENCE CENTERS
    • PATENTS
    • TRANSLATIONS
    • INSURANCES
    • FUNDING
    • WEBSITES & ICT SERVICES
How to resolve AdBlock issue?
Refresh this page
Filters
List of articles in category CYBERPHARMA EXCELLENCE NEWS
Title Author Hits
COVID-19, Federfarma invita a segnalare abusi e chiede deroghe per vendibilità mascherine in farmacia Written by Cyberpharmaexcellence Hits: 1334
Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens Written by Cyberpharmaexcellence Hits: 1782
UPDATED: COVID-19 PHARMA TRACKER Written by Cyberpharmaexcellence Hits: 1795
Coronavirus: Credifarma sostiene le farmacie in prima linea con finanziamento in caso di sospensione dell’attività Written by Cyberpharmaexcellence Hits: 1437
Coronavirus: impegno della filiera farmaceutica per garantire produzione e distribuzione su tutto il territorio nazionale Written by Cyberpharmaexcellence Hits: 1639
FDA postpones overseas inspections through April as COVID-19 cases increase Written by Cyberpharmaexcellence Hits: 1651
Rischio di disturbi psichiatrici da farmaco per allergie L'Fda invita i medici a non prescriverlo per i casi lievi Written by Cyberpharmaexcellence Hits: 1347
Coronavirus, a rischio produzione farmaci in India. In Europa nessuna carenza Written by Cyberpharmaexcellence Hits: 1307
Farmaci, attesi per fine anno in Europa 76 nuovi medicinali Written by Cyberpharmaexcellence Hits: 1548
Due vecchi farmaci aiutano rigenerazione ossea dopo fratture Studio condotto all'Imperial College London Written by Cyberpharmaexcellence Hits: 1810

Page 15 of 16

  • Start
  • Prev
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
  • End
How to resolve AdBlock issue?
Refresh this page

 

CYBERPHARMA EXCELLENCE

bY - M.A.B. Art Decò

Piazzale A. La Marmora, 13
01030 Monterosi (VT) ITALY
P.IVA: 08724920585

N° ROC REGISTER: 21797

 

 

Facebook

Follow us on facebook

qr-code

Cookie

Cookie Policy

Privacy

Privacy Policy

Visitorcounter

All 724322

Currently are 8 guests and no members online

GDPR Data Collection

GDPR

Copyright Cyberpharma Excellence © 2020. All Rights Reserved.

Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok
More information